Skip to main content

Table 5 Hematological values at screening, baseline, day 28 and day 56

From: Prospective, randomized, double-blinded, placebo-controlled study on safety and tolerability of the krill powder product in overweight subjects with moderately elevated blood pressure

Parameter (unit)

Krill powder, mean value (n = 18)

Krill powder, SD

Placebo, mean value (n = 17)

Placebo, SD

P-value (Krill powder vs. Placebo)

B-Hb (g/L)

 SCR

147.8

11.2

146.1

8.4

 

 BAS

146.2

10.2

144.2

8.1

 

 D28

147.4

11.2

145.1

8.7

0.8074

 D56

145.6

11.6

143.8

7.3

0.9517

B-HCT (%)

 SCR

44.3

2.9

43.9

2.1

 

 BAS

43.4

2.8

42.8

2.5

 

 D28

44.5

2.4

44.3

2.2

0.7642

 D56

44.1

3.2

43.1

2.3

0.3581

E-MCV (fL)

 SCR

90.1

4.7

88.5

4.6

 

 BAS

89.5

4.7

87.2

4.2

 

 D28

90.8

4.7

89.6

5.4

0.2584

 D56

90.8

4.9

88.7

5.2

0.9008

E-MCH (pg)

 SCR

30.1

2.3

29.5

1.8

 

 BAS

30.2

2.1

29.5

1.9

 

 D28

30.1

2.4

29.5

2.0

0.6181

 D56

30.1

2.2

29.7

2.0

0.1709

  1. SCR screening, BAS baseline, B-Hb bood hemoglobin, B-HCT blood hematocrit, E-MCV erythrocyte mean corpuscular volume, E-MCH mean corpuscular hemoglobin
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X